Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,362 public trials 1,306 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Molecular-Guided Therapy for Childhood Cancer

NCT02162732

Conditions
Adenocarcinoma, Brain Diseases, Brain Neoplasms, +65 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rady Children's Hospital San Diego, California, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
View all 19 locations
View Trial Details
Completed

A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

NCT05809934

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +6 more
Locations
  • Research Site Chandler, Arizona, United States
  • Research Site Peoria, Arizona, United States
  • Research Site Surprise, Arizona, United States
  • Research Site Tucson, Arizona, United States
View all 164 locations
View Trial Details
Completed

A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors

NCT05091346

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, Irvine Health Orange, California, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • SCRI Florida Cancer Specialists East West Palm Beach, Florida, United States
View all 32 locations
View Trial Details
Completed

Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV)

NCT03365947

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Research Site 5 Camperdown, New South Wales, Australia
  • Research Site 4 Clayton, Victoria, Australia
  • Research Site 3 Melbourne, Victoria, Australia
  • Research Site 6 Nedlands, Western Australia, Australia
View Trial Details
Completed

A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)

NCT06052566

Conditions
Digestive System Diseases, Fatty Liver, Hepatic Impairment, +3 more
Locations
  • Clinical Pharmacology of Miami ( Site 0005) Miami, Florida, United States
  • Advanced Pharma CR, LLC ( Site 0001) Miami, Florida, United States
  • Genesis Clinical Research, LLC ( Site 0006) Tampa, Florida, United States
  • American Research Corporation ( Site 0002) San Antonio, Texas, United States
View Trial Details
Completed

A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV

NCT05904470

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +19 more
Locations
  • Atea Study Site San Antonio, Texas, United States
  • Atea Study Site Manaus, Amazonas, Brazil
  • Atea Study Site Salvador, Estado de Bahia, Brazil
  • Atea Study Site Brasília, Federal District, Brazil
View all 51 locations
View Trial Details

Related conditions